Literature DB >> 19360878

Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the persistent arterial duct.

Jonathan Forsey1, Damien Kenny, Gareth Morgan, Alison Hayes, Mark Turner, Andrew Tometzki, Robin Martin.   

Abstract

OBJECTIVES: To describe the early single-center clinical experience with the Amplatzer Ductal Occluder II (ADO II).
METHODS: All patients undergoing attempted transcatheter closure of persistent arterial duct (PDA) with the ADO II were included. Data collected included demographic, clinical, and echocardiographic parameters.
RESULTS: From March until September 2008, 29 procedures were undertaken in 27 patients (21 female). Median age was 1.4 years (range 0.4-76 years) with median weight 9.4 kg (range 4.7-108 kg). A transarterial approach was used in 2 patients. The median minimum ductal diameter was 2.7 mm (range 1.7-5). ADO II was released in 25 patients (92.5%). Two patients had significant residual shunting following deployment of ADO II and underwent closure with Amplatzer ductal occluder (ADO I). Postprocedural echocardiography identified one occluder had changed position with development of a significant leak and one occluder had embolized to the left pulmonary artery. Both occluders were retrieved successfully at a second catheter procedure. Complete occlusion was noted predischarge in 22 of the remaining 23 occluders (96%). One patient had mild flow acceleration in the left pulmonary artery which has resolved.
CONCLUSIONS: The ADO II is highly effective at providing rapid occlusion of morphologically varied PDAs. Occluder design allows closure with arterial or venous approach and delivery with 4 or 5 F delivery catheters. Stable occluder position is dependent on correct positioning of both aortic and pulmonary discs. A larger range of sizes and configurations of this occluder may be required to successfully occlude all ductal sizes and morphologies.

Entities:  

Mesh:

Year:  2009        PMID: 19360878     DOI: 10.1002/ccd.22055

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  9 in total

1.  Comparison of the efficacy of different-sized Amplatzer duct occluders (I, II, and II AS) in children weighing less than 10 kg.

Authors:  Osman Baspinar; Ahmet Irdem; Ercan Sivasli; Derya Aydin Sahin; Metin Kilinc
Journal:  Pediatr Cardiol       Date:  2012-05-31       Impact factor: 1.655

2.  Transcatheter closure of patent ductus arteriosus and interruption of inferior vena cava with azygous continuation using an Amplatzer duct occluder II.

Authors:  Ghee Tiong Koh; Sharifah Ai Mokthar; Amir Hamzah; Jasvinder Kaur
Journal:  Ann Pediatr Cardiol       Date:  2009-07

3.  Percutaneous closure of a moderate to large tubular or elongated patent ductus arteriosus in children younger than 3 years: is the ADO II appropriate?

Authors:  Saktheeswaran Mahesh Kumar; Venkateshwaran Subramanian; Sasidharan Bijulal; Kavassery Mahadevan Krishnamoorthy; Sivasubramonian Sivasankaran; Jaganmohan A Tharakan
Journal:  Pediatr Cardiol       Date:  2013-04-17       Impact factor: 1.655

Review 4.  Severe spinal cord ischemic injury secondary to device embolization after transcatheter closure of a patent arterial duct.

Authors:  Liang Tang; Shenghua Zhou; Xiangqian Shen
Journal:  Tex Heart Inst J       Date:  2014-02

5.  Transcatheter closure of ventricular septal defects using the Amplatzer Duct Occluder II device: a single-center experience.

Authors:  Tugcin Bora Polat; Esma Türkmen
Journal:  Postepy Kardiol Interwencyjnej       Date:  2016-11-17       Impact factor: 1.426

6.  Do we need a femoral artery route for transvenous PDA closure in children with ADO-I?

Authors:  Ali Baykan; Nazmi Narin; Abdullah Özyurt; Mustafa Argun; Özge Pamukçu; Sertaç H Onan; Sadettin Sezer; Zeynep Baykan; Kazım Üzüm
Journal:  Anatol J Cardiol       Date:  2014-04-16       Impact factor: 1.596

7.  Fenestration closure with Amplatzer Duct Occluder II in patients after total cavo-pulmonary connection.

Authors:  Sebastian Góreczny; Paweł Dryżek; Gareth J Morgan; Anna Mazurek-Kula; Jacek J Moll; Jadwiga A Moll; Shakeel Qureshi; Tomasz Moszura
Journal:  Arch Med Sci       Date:  2016-11-28       Impact factor: 3.318

8.  Cost-effectiveness analysis of different devices used for the closure of small-to-medium-sized patent ductus arteriosus in pediatric patients.

Authors:  Sonia A El-Saiedi; Amal M El Sisi; Rodina Sobhy Mandour; Doaa M Abdel-Aziz; Wael A Attia
Journal:  Ann Pediatr Cardiol       Date:  2017 May-Aug

9.  A case report on the successful interventional treatment of a rare cause of left heart failure in a 69-year-old woman.

Authors:  Tomaz Podnar; Fabian Plank; Silvana Müller; Johannes Mair
Journal:  Eur Heart J Case Rep       Date:  2020-11-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.